Publikationsliste Prof. Dr. Oliver Plettenburg
Zeige Ergebnisse 51 - 60 von 70
2014
Hu, H. Y., Vats, D., Vizovisek, M., Kramer, L., Germanier, C., Wendt, K. U., Rudin, M., Turk, B., Plettenburg, O., & Schultz, C. (2014). In Vivo Imaging of Mouse Tumors by a Lipidated Cathepsin Substrate. Angewandte Chemie - International Edition, 53(29), 7669-7673. https://doi.org/10.1002/anie.201310979
Hu, H. Y., Gehrig, S., Reither, G., Subramanian, D., Mall, M. A., Plettenburg, O., & Schultz, C. (2014). FRET-based and other fluorescent proteinase probes. Biotechnology journal, 9(2), 266-281. https://doi.org/10.1002/biot.201300201
2013
Babelova, A., Jansen, F., Sander, K., Löhn, M., Schäfer, L., Fork, C., Ruetten, H., Plettenburg, O., Stark, H., Daniel, C., Amann, K., Pavenstädt, H., Jung, O., & Brandes, R. P. (2013). Activation of Rac-1 and RhoA Contributes to Podocyte Injury in Chronic Kidney Disease. PLOS ONE, 8(11), Artikel e80328. https://doi.org/10.1371/journal.pone.0080328
2012
McNicholas, T. P., Yum, K., Ahn, J. H., Mu, B., Plettenburg, O., Gooderman, A., Natesan, S., & Strano, M. S. (2012). Structure and Function of Glucose Binding Protein–Single Walled Carbon Nanotube Complexe. SMALL, 8(22), 3510-3516. https://doi.org/10.1002/smll.201200649
Grisk, O., Schlüter, T., Reimer, N., Zimmermann, U., Katsari, E., Plettenburg, O., Löhn, M., Wollert, H. G., & Rettig, R. (2012). The Rho kinase inhibitor SAR407899 potently inhibits endothelin-1-induced constriction of renal resistance arteries. Journal of hypertension, 30(5), 980-989. https://doi.org/10.1097/HJH.0b013e328351d459
2009
Löhn, M., Plettenburg, O., Ivashchenko, Y., Kannt, A., Hofmeister, A., Kadereit, D., Schaefer, M., Linz, W., Kohlmann, M., Herbert, J. M., Janiak, P., O'Connor, S. E., & Ruetten, H. (2009). Pharmacological Characterization of SAR407899, a Novel Rho-Kinase Inhibitor. Hypertension, 54(3), 676-683. https://doi.org/10.1161/HYPERTENSIONAHA.109.134353
2008
Bickel, M., Brummerhop, H., Frick, W., Glombik, H., Herling, A. W., Heuer, H. O., Plettenburg, O., Theis, S., Werner, U., & Kramer, W. (2008). Effects of AVE2268, a Substituted Glycopyranoside, on Urinary Glucose Excretion and Blood Glucose in Mice and Rats. Arzneimittel-Forschung/Drug Research, 58(11), 574-580. https://doi.org/10.1055/s-0031-1296559
2005
Podeschwa, M. A. L., Plettenburg, O., & Altenbach, H. J. (2005). Flexible Stereo- and Regioselective Synthesis ofmyo-Inositol Phosphates(Part 1): Via Symmetrical Conduritol B Derivatives. European Journal of Organic Chemistry, 2005(14), 3101-3115. https://doi.org/10.1002/ejoc.200400911
Podeschwa, M. A. L., Plettenburg, O., & Altenbach, H. J. (2005). Flexible Stereo- and Regioselective Synthesis of myo-Inositol Phosphates (Part 2): Via Nonsymmetrical Conduritol B Derivatives. European Journal of Organic Chemistry, 2005(14), 3116-3127. https://doi.org/10.1002/ejoc.200400918
Steioff, K., Rütten, H., Busch, A. E., Plettenburg, O., Ivashchenko, Y., & Löhn, M. (2005). Long term Rho-kinase inhibition ameliorates endothelial dysfunction in LDL-receptor deficient mice. European journal of pharmacology, 512(2-3), 247-249. https://doi.org/10.1016/j.ejphar.2005.03.001
